Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,521,062
+$2,054,596 QoQ
Shares Held
31,620
+155.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#111
of 334 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $10,389,461 across 8 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
61,555 | $2,525,601 | |
| 2 | LQDA |
Liquidia Corp
This page
|
31,620 | $2,521,062 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
48,037 | $1,738,939 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
8,505 | $1,433,432 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
37,396 | $1,174,234 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
93,689 | $394,430 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
38,501 | $322,638 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
19,079 | $279,125 |
All Filings in LQDA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,521,062 | 31,620 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $466,466 | 12,360 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $442,403 | 12,827 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||